Novel Drugs and Clinical Trial-Based Treatments Prolong Survival of Peripheral T-Cell Lymphomas (PTCL) Patients: Single Institution Retrospective Analysis

被引：0
|
作者：
Ma, Helen [1 ]
Marchi, Enrica [2 ]
Cheng, Bin [3 ]
Bhagat, Govind [3 ]
O'Connor, Owen A. [2 ]
机构：
[1] Columbia Univ, Med Ctr, New York Presbyterian Hosp, New York, NY USA
[2] Columbia Univ, Dept Med, Med Ctr, Ctr Lymphoid Malignancies, New York, NY USA
[3] Columbia Univ, Med Ctr, New York, NY USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-123587
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3486
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Salvage chemotherapy of gemcitabine, dexamethasone, and cisplatin (GDP) for patients with relapsed or refractory peripheral T-cell lymphomas: a consortium for improving survival of lymphoma (CISL) trial
    Park, Byeong-Bae
    Kim, Won Seog
    Suh, Cheolwon
    Shin, Dong-Yeop
    Kim, Jeong-A
    Kim, Hoon-Gu
    Lee, Won Sik
    ANNALS OF HEMATOLOGY, 2015, 94 (11) : 1845 - 1851
  • [32] Salvage chemotherapy of gemcitabine, dexamethasone, and cisplatin (GDP) for patients with relapsed or refractory peripheral T-cell lymphomas: a consortium for improving survival of lymphoma (CISL) trial
    Byeong-Bae Park
    Won Seog Kim
    Cheolwon Suh
    Dong-Yeop Shin
    Jeong-A Kim
    Hoon-Gu Kim
    Won Sik Lee
    Annals of Hematology, 2015, 94 : 1845 - 1851
  • [33] A retrospective clinical analysis of Japanese patients with peripheral T-cell lymphoma not otherwise specified: Hokkaido Hematology Study Group
    Yoshihiro Torimoto
    Kazuya Sato
    Katsuya Ikuta
    Toshiaki Hayashi
    Yasuo Hirayama
    Junki Inamura
    Hajime Kobayashi
    Ryoji Kobayashi
    Kyuhei Koda
    Mitsutoshi Kurosawa
    Akio Mori
    Shuichi Ota
    Hajime Sakai
    Akio Shigematsu
    Motohiro Shindo
    Hitoshi Shinzaki
    Fumihiko Takahashi
    Rishu Takimoto
    Junji Tanaka
    Satoshi Yamamoto
    Yutaka Kohgo
    Takashi Fukuhara
    International Journal of Hematology, 2013, 98 : 171 - 178
  • [34] A retrospective clinical analysis of Japanese patients with peripheral T-cell lymphoma not otherwise specified: Hokkaido Hematology Study Group
    Torimoto, Yoshihiro
    Sato, Kazuya
    Ikuta, Katsuya
    Hayashi, Toshiaki
    Hirayama, Yasuo
    Inamura, Junki
    Kobayashi, Hajime
    Kobayashi, Ryoji
    Koda, Kyuhei
    Kurosawa, Mitsutoshi
    Mori, Akio
    Ota, Shuichi
    Sakai, Hajime
    Shigematsu, Akio
    Shindo, Motohiro
    Shinzaki, Hitoshi
    Takahashi, Fumihiko
    Takimoto, Rishu
    Tanaka, Junji
    Yamamoto, Satoshi
    Kohgo, Yutaka
    Fukuhara, Takashi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 98 (02) : 171 - 178
  • [35] Sufficient and Timely Autologous Stem Cell Harvest After Chemoimmunotherapy with Alemtuzumab In Combination with Bi-Weekly CHOP as First Line Treatment In Systemic Peripheral T-Cell Lymphomas (PTCL): a Feasibility Analysis From the First Randomized Trial In Systemic PTCL (ACT trial)
    d'Amore, Francesco
    da Silva, Maria Gomes
    Leppa, Sirpa
    Pezzutto, Antonio
    Relander, Thomas
    Lauritzsen, Grete Fossum
    Weidmann, Eckhart
    Van Gelder, Michel
    Doorduijn, Jeanette
    Kluin-Nelemans, J. C.
    Kooy, Marinus van Marwijk
    Fijnheer, Rob
    de Weerdt, Okke
    Brown, Peter de Nully
    Hansen, Per Boye
    Merup, Mats
    Grube, Matthias
    Mariz, Jose Mario
    Walewski, Jan
    Truemper, Lorenz
    Wulf, Gerald
    Jantunen, Esa
    Hopfinger, Georg
    Prochazka, Vit
    BLOOD, 2010, 116 (21) : 992 - 993
  • [36] Case Match Control Analysis of Propel Reveals Survival Advantage for Patients with Relapsed/Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL) Treated with Pralatrexate
    O'Connor, Owen A.
    Marchi, Enrica
    Volinn, Weining
    Kim, Won Seog
    BLOOD, 2016, 128 (22)
  • [37] CHOP in Combination with Pralatrexate, a Novel Folate Analogue Metabolic Inhibitor in Patients with Previously Untreated Peripheral T-Cell Lymphoma (PTCL): Interim Results of the Phase 1 Trial
    Shustov, Andrei R.
    Oki, Yasuhiro
    Barta, Stefan Klaus
    Johnston, Patrick B.
    Sharma, Pankaj
    Song, Tao
    Mourya, Sanjay
    BLOOD, 2016, 128 (22)
  • [38] Evaluation of clinical trial eligibility and prognostic indices in a population-based cohort of systemic peripheral T-cell lymphomas from the Danish Lymphoma Registry
    Pedersen, Martin Bjerregaard
    Hamilton-Dutoit, Stephen Jacques
    Bendix, Knud
    Moller, Michael Boe
    Norgaard, Peter
    Johansen, Preben
    Ralfkiaer, Elisabeth
    Brown, Peter De Nully
    Hansen, Per Boye
    Jensen, Bo Amdi
    Madsen, Jakob
    Schollkopf, Claudia
    d'Amore, Francesco
    HEMATOLOGICAL ONCOLOGY, 2015, 33 (04) : 120 - 128
  • [39] A retrospective single institute analysis of 127 lymphoma patients who underwent allogeneic stem cell transplantation: Impact on peripheral T cell lymphoma (PTCL) including ATLL.
    Tanosaki, Ryuji
    Kim, Sung-Won
    Yamazaki, Satoshi
    Fukuda, Takahiro
    Mori, Shin-ichiro
    Heike, Yuji
    Tobinai, Kensei
    Takaue, Yoichi
    BLOOD, 2006, 108 (11) : 861A - 861A
  • [40] Clinical characteristics and survival of extranodal natural killer/T-cell lymphoma: a single-center 12-year retrospective analysis
    Chen, Yi
    Luo, Luting
    Zheng, Xiaoyun
    Fu, Haiying
    Yang, Xiaozhu
    Huang, Wanling
    Chen, Lushan
    Zheng, Zhihong
    Zheng, Jing
    Yang, Ting
    Liu, Tingbo
    Hu, Jianda
    LEUKEMIA & LYMPHOMA, 2020, 61 (14) : 3306 - 3318
12345